In a shocking development, specific batches of 60 drugs, some of which have been widely used, have failed quality tests in a sample-based screening conducted by the national drug regulatory agency Central Drugs Standard Control Organisation (CDSCO).
Popular medicines such as painkiller Combiflam, over-the-counter cold medication D Cold, anti-allergy drug Cetirizin and antibiotics containing Ciprofloxacin, Ofloxacin and Amoxycilin have been declared ‘sub-standard’ by the regulatory authority.
These drugs feature in the list put up by CDSCO titled ‘Drug Alert for the Month of March’ on the agency’s website and have been tested in CDSCO’s zonal offices. Findings of the test declare the drugs as ‘Not of Standard Quality’, ‘Spurious’, ‘Adulterated’ or ‘Misbranded.’
According to the report, the widely-consumed painkiller Combiflam and the cold medication D Cold have been declared sub-standard because they failed the disintegration test. Likewise, antibiotics Ciprofloxacin, Ofloxacin and Amoxycillin have been featured in the list due to assay. Panza-40, a medicine prescribed for reducing stomach acid, has also made it to the list due to ‘dissolution.’
The details of all the 60 drugs which includes their composition, manufacture and expiry date, names of manufacturers, the reasons for failure and the zonal offices where they are drawn from are mentioned on the list put up on the website.